Maximizing the Potential of the New Advanced Research Projects Agency for Health (ARPA-H) 

-

This session will open with a conversation with Representative Anna Eshoo, followed by a panel discussion on ARPA-H.

The signature achievements of the federal Defense Advanced Research Projects Agency (DARPA) are well known. Among them were early iterations of the internet, wireless communication, speech recognition, and global positioning systems. More than a decade of advocacy for a similar agency targeting high-risk, high-reward innovations in health has borne fruit in the creation of the Advanced Research Projects Agency for Health (ARPA-H) in 2022. What problems should this new entity focus on solving? How should ARPA-H be structured if it is to achieve the same quality of breakthroughs as DARPA? 

    Guest

    Image

    Anna
     
    Eshoo
     

    US Representative, California; Chair, US House Energy and Commerce Subcommittee on Health

    Moderator

    Image

    Margaret
     
    Anderson
     

    Managing Director, Deloitte
    Image

    Esther
     
    Krofah
     

    Executive Vice President, MI Health, Milken Institute

    Speaker

    Image

    Christopher
     
    Austin
     

    CEO and Partner, Flagship Pioneering
    Image

    Howard
     
    Fillit
     

    Co-Founder and Chief Science Officer, Alzheimer's Drug Discovery Foundation
    SM

    Susan
     
    Monarez
     

    Acting Deputy Director, Advanced Research Projects Agency for Health (ARPA-H)
    Image

    Tara
     
    Schwetz
     

    Acting Principal Deputy Director, National Institutes of Health
    Image

    Michael
     
    Stebbins
     

    President, Science Advisors